Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6330601rdf:typepubmed:Citationlld:pubmed
pubmed-article:6330601lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:6330601lifeskim:mentionsumls-concept:C0927232lld:lifeskim
pubmed-article:6330601lifeskim:mentionsumls-concept:C1167398lld:lifeskim
pubmed-article:6330601lifeskim:mentionsumls-concept:C0017950lld:lifeskim
pubmed-article:6330601lifeskim:mentionsumls-concept:C1561577lld:lifeskim
pubmed-article:6330601lifeskim:mentionsumls-concept:C1514811lld:lifeskim
pubmed-article:6330601lifeskim:mentionsumls-concept:C1706462lld:lifeskim
pubmed-article:6330601pubmed:issue1lld:pubmed
pubmed-article:6330601pubmed:dateCreated1984-8-13lld:pubmed
pubmed-article:6330601pubmed:abstractTextMany viruses, with lipid envelopes derived from the host cell membranes, have been implicated in the aetiology of multiple sclerosis (MS), and epidemiological studies support an infectious agent. Alternatively the disease is thought by other workers to be auto-immune in nature, and recently much attention has been focused on immunological sensitivity to glycolipids in MS patients. In this paper it is proposed that CNS demyelination could arise in susceptible individuals (HLA type) from an immune response to glycolipids, triggered by the carrier effect of one or more enveloped neurotropic viruses.lld:pubmed
pubmed-article:6330601pubmed:languageenglld:pubmed
pubmed-article:6330601pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6330601pubmed:citationSubsetIMlld:pubmed
pubmed-article:6330601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6330601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6330601pubmed:statusMEDLINElld:pubmed
pubmed-article:6330601pubmed:issn0305-1846lld:pubmed
pubmed-article:6330601pubmed:authorpubmed-author:WebbH EHElld:pubmed
pubmed-article:6330601pubmed:authorpubmed-author:FazakerleyJ...lld:pubmed
pubmed-article:6330601pubmed:issnTypePrintlld:pubmed
pubmed-article:6330601pubmed:volume10lld:pubmed
pubmed-article:6330601pubmed:ownerNLMlld:pubmed
pubmed-article:6330601pubmed:authorsCompleteYlld:pubmed
pubmed-article:6330601pubmed:pagination1-10lld:pubmed
pubmed-article:6330601pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:meshHeadingpubmed-meshheading:6330601-...lld:pubmed
pubmed-article:6330601pubmed:articleTitleCan viral envelope glycolipids produce auto-immunity, with reference to the CNS and multiple sclerosis?lld:pubmed
pubmed-article:6330601pubmed:publicationTypeJournal Articlelld:pubmed